Recurrence: all 3,523 studies
Page 6 of 36. Open to participants first (870), then studies with results posted, then the rest; newest registration first within each.
- A Study of ARV-393 in Relapsed/Refractory Non-Hodgkin Lymphoma.RecruitingNCT06393738Phase 1
- A Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of SSGJ-705 Monotherapy in Patients with Advanced Malignant TumorsRecruitingNCT06390774Phase 1
- Pretreatment With HCQ Before Radiotherapy and Chemotherapy in Advanced NPC PatientsRecruitingNCT06389201Not applicable
- Efficacy and Safety of MTBF Conditioning Regimen for Salvageable Allo-HSCT in the Treatment of R/R AMLNot yet recruitingNCT06385808Not applicable
- SNC115 Injections in Patients With Recurrent/Refractory Small Cell Lung Cancer and Lung Large Cell Neuroendocrine CarcinomaRecruitingNCT06384482Phase 1
- Evaluation of Outcomes of the Triathlon Hinge Knee (THK) SystemRecruitingNCT06379321
- Ziftomenib in Combination With Chemotherapy for Children With Relapsed/Refractory Acute LeukemiaRecruitingNCT06376162Phase 1
- A Study of GFH009 in Combination With Zanubrutinib in Subjects With Relapsed or Refractory DLBCLRecruitingNCT06375733Phase 1/2
- Study of SIM0500 Alone in Participants With Relapsed or Refractory Multiple MyelomaRecruitingNCT06375044Phase 1
- Clinical Trial of ssCART-19 Cell Injection in the Treatment of Relapsed or Refractory Acute Lymphoblastic Leukemia (Including Central Nervous System Infiltration)Not yet recruitingNCT06367114Phase 2
- WoW - Single- vs Two-staged Excisions of Thin MelanomaRecruitingNCT06363591Not applicable
- Intraarterial Carboplatin + Caelyx vs Intraarterial Carboplatin + Etoposide Phosphate for Progressing GlioblastomaRecruitingNCT06356883Phase 2
- Study of Autologous CAR-T Cells Targeting B7-H3 in TNBC iC9-CAR.B7-H3 T CellsRecruitingNCT06347068Phase 1
- AutologousCD22 Chimeric Antigen Receptor (CAR)T Cells in w/Recurrent/Refractory B Cell LymphomasRecruitingNCT06340737Phase 1
- Blinatumomab for Relapsed Acute B Lymphoblastic Leukemia After TransplantationRecruitingNCT06339775Phase 4
- A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)RecruitingNCT06330064Phase 1/2
- Anesthesia and Non-small Cell Lung Cancer RecurrenceRecruitingNCT06330038Phase 4
- Intraperitoneal Cytokine-Induced Memory Like (CIML) Natural Killer (NK) Cells in Recurrent Ovarian CancerRecruitingNCT06321484Phase 1
- Value of Dynamic Monitoring of Early Recurrence of Hepatocellular Carcinoma After Radical Resection Based on CTCSNot yet recruitingNCT06317896
- Safety and Efficacy of Avapritinib in Relapsed or Refractory Pediatric CBF-AML With KIT MutationRecruitingNCT06316960Phase 2
- Efficacy and Safety of Neoadjuvant Therapy in Patients With Resectable HCC Screened by a Multimodal Deep Learning Model.Not yet recruitingNCT06311916Phase 4
- Autologous CAR-T Cells Targeting B7H3 in Ovarian Cancer iC9-CAR.B7-H3 T CellsRecruitingNCT06305299Phase 1
- To Assess Safety, Tolerability, and Efficacy of Anti-GPRC5D-CD19-CAR-T in Relapsed/Refractory Multiple MyelomaNot yet recruitingNCT06298266Early Phase 1
- Study of Arlocabtagene Autoleucel (BMS-986393) a GPRC5D-directed CAR T Cell Therapy in Adult Participants With Relapsed or Refractory Multiple MyelomaRecruitingNCT06297226Phase 2
- Safety/Tolerability, PK and Efficacy of IMB071703 Injection in Patients With Advanced Solid TumorsRecruitingNCT06292858Phase 1
- A Trial to Learn if Linvoseltamab is Safe and Works in Adults With Relapsed or Refractory Systemic Light Chain Amyloidosis (AL Amyloidosis)RecruitingNCT06292780Phase 1/2
- Comparison of Retention Characteristics of Immediate vs Delayed Retainer Delivery Using 3D Digital Model AnalysisRecruitingNCT06292364Not applicable
- Epcoritamab (Epcor)-Containing Combination Salvage Therapy Followed by ASCT & Epcor Consolidation in Patients With Relapsed LBCLRecruitingNCT06287398Phase 2
- Phase Ib/II Study Assessing the Clinical Activity and Safety of Brexucabtagene Autoleucel as a Consolidation in Patients With Relapsed/Refractory (R/R) and Newly Diagnosed B-cell Acute Lymphocytic Leukemia (ALL) Post Cytoreduction With Mini-HCVD-inotuzumab-blinatumomab/HCVAD-inotuzumab-blinatumomabRecruitingNCT06287229Phase 1/2
- An Adaptive Open-label Multicentre Phase 1/2 Trial, to Determine the Recommended Phase 2 Dose of CCTx-001, and to Assess Safety, Tolerability, and Clinical Activity in Patients With Relapsed/Refractory Acute Myeloid LeukaemiaNot yet recruitingNCT06281847Phase 1/2
- The RECMAP-study: Resection With or Without Intraoperative Mapping for Recurrent GlioblastomaRecruitingNCT06273176
- Multicenter, Platform-type Clinical Study of Refractory/Recurrent Acute Myeloid LeukemiaRecruitingNCT06265545Not applicable
- Special Drug Use-results Surveillance of Tafinlar/MekinistRecruitingNCT06262919
- Combined Relapse Prediction Model for Resectable Non-Small Cell Patients - a Prospective Clinical Feasibility TrialRecruitingNCT06262386Not applicable
- A Clinical Study of SCTC21C in Participants With CD38+ Hematologic MalignanciesRecruitingNCT06252298Phase 1
- Plan Development for Giving Teclistamab in the Outpatient SettingRecruitingNCT06251076Phase 4
- New Relapse Model in PsychiatryRecruitingNCT06244641Not applicable
- Autologous Tumor Infiltrating Lymphocytes (GT101 Injection) in Patients With Recurrent or Metastatic Cervical CancerRecruitingNCT06241781Phase 2
- A Multi-center, Randomized, Double-blind, Phase II/III Clinical Trial of AK104 or Placebo in Combination With Chemotherapy as Second-line or More Lines for Recurrent or Metastatic Nasopharyngeal Carcinoma (NPC)RecruitingNCT06241599Phase 2/3
- Risk Factors and A Prediction Model of Recurrence of Uterine FibroidsNot yet recruitingNCT06234670
- Individualized Treatment of Pediatric R/R AML Based on Transcriptomic Profile and in Vitro Drug Sensitivity TestRecruitingNCT06233526Not applicable
- A Study of MBS314 in Participants With Relapsed/Refractory Multiple Myeloma.RecruitingNCT06232096Phase 1/2
- Periodontal Plastic Reconstruction of Soft Tissue Dehiscences After the Removal of Localized Gingival EnlargementsRecruitingNCT06210789Not applicable
- Optimal Precision TherapIes to CustoMISE Care in Childhood and Adolescent CancerRecruitingNCT06208657Phase 1/2
- Investigation of Multi-omics Technique to Predict the Efficacy of Chemoradiotherapy Combined With Immunotherapy for r/m NPCRecruitingNCT06197776
- A Study to Evaluate MK-1045 (CN201) in Participants With Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma (MK-1045-001/CN201-101)RecruitingNCT06189391Phase 1
- Allogeneic Immunotherapy of Hematological Malignancies Using Regulatory T-cell Selective DepletionNot yet recruitingNCT06180499Phase 1/2
- A Study of CD19 Targeted CAR T Cell Therapy in Pediatric Patients With Relapsed or Refractory B Cell Acute Lymphoblastic Leukemia (B ALL) and Aggressive Mature B-cell Non-Hodgkin Lymphoma (B NHL)RecruitingNCT06173518Phase 1
- Translational Cancer Observational ProtocolRecruitingNCT06169436
- PLX038 in Primary Central Nervous System Tumors Containing MYC or MYCN AmplificationsRecruitingNCT06161519Phase 1/2
- Autologous CAR-T Cells Targeting B7-H3 in PDACRecruitingNCT06158139Phase 1
- Cabozantinib With Ifosfamide in Relapsed/Refractory SarcomasRecruitingNCT06156410Phase 1
- A Prospective Real-world Study of Cadonilimab in Patients With Recurrent or Metastatic Cervical CancerNot yet recruitingNCT06155422
- Retrospective Cervical Cancer Oligo States (Recurrence, Metastasis) Multicentre Outcomes StudyNot yet recruitingNCT06150222
- A Trial to Find Out if Odronextamab Combined With Lenalidomide is Safe and Works Better Than Rituximab Combined With Lenalidomide in Adult Participants With Follicular Lymphoma and Marginal Zone LymphomaRecruitingNCT06149286Phase 3
- Kidney Cancer Observational ProtocolRecruitingNCT06147349
- Safety, Pharmacokinetics, and Clinical Activity of LP-284 in Adult Patients With Relapsed or Refractory Lymphomas and Solid TumorsRecruitingNCT06132503Phase 1
- TBI/Flu/Bu/Mel Combined With Secondary UCBT in Patients With Hematological Malignancies Who Relapsed After Allo-HSCTRecruitingNCT06125483Not applicable
- SHR2554 Clinical Study of Chidamide in the Treatment of T-cell LymphomaRecruitingNCT06122389Phase 3
- Neurobehavioral Profiles of Adaptive Stress Responses in Individuals With Alcohol Use DisorderRecruitingNCT06105853Not applicable
- BGT007 Cells for the Treatment of Refractory Digestive System TumorsRecruitingNCT06104241Early Phase 1
- BGT007H Cells for the Treatment of Refractory Digestive System TumorsRecruitingNCT06104215Early Phase 1
- Safety and Superiority of Penicillamine in Radiosensitization of Recurrent Head and Neck CancerRecruitingNCT06103617Phase 2
- Prognostic Factors Affecting Recurrence and Disease-Free Survival After Surgical Resection for Cancer RectumRecruitingNCT06096493
- Autologous CAR-T Cells Targeting CSPG4 in Relapsed/Refractory HNSCCRecruitingNCT06096038Phase 1
- An Exploratory Study of A-337 in the Management of Malignant Solid Dose Escalation and Expansion PhasesNot yet recruitingNCT06093698Phase 1
- Prevention of Recurrence and Metastasis of Colorectal Cancer by Comparing Huaier With Capecitabine MonotherapyRecruitingNCT06090994Phase 4
- ATLCAR.CD30.CCR4 for CD30+ HL ATLCAR.CD30.CCR4 CellsRecruitingNCT06090864Phase 1/2
- Safety of Omitting Axillary Surgery in Breast Cancer Patients With Isolated Chest Wall RecurrenceRecruitingNCT06088719
- Thyroxine Replacement Therapy After Lobectomy for Low-risk Papillary Thyroid CarcinomaRecruitingNCT06087068Phase 2
- A-RGEMOX in the Treatment of Early Relapsed/Refractory DLBCLRecruitingNCT06086197Phase 2
- A Study of DeepTag-GPRC5D Targeted CAR-T Cells Therapy for Refractory/Relapsed Multiple MyelomaRecruitingNCT06084962Phase 1
- A Prospective, Open-label, Multicenter, Randomized Controlled Phase III Study of Prophylactic Central Neck Dissection in Low-risk Papillary Thyroid CancerRecruitingNCT06082180Phase 3
- CD7-CAR-T Cells in Pediatric Relapsed/Refractory CD7+ T-ALL/LLRecruitingNCT06064903Phase 1/2
- A Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastatic (R/M) HPV Negative Head and Neck Squamous Cell CarcinomaRecruitingNCT06064877Phase 3
- A Study of SR-8541A (ENPPI Inhibitor) in Advanced/Metastatic Solid TumorsRecruitingNCT06063681Phase 1
- Selinexor Combined With R-GDP Regimen for TP53-altered R/R DLBCLNot yet recruitingNCT06062641Phase 2
- Pulsed Dose Chemotherapy Plus Pembrolizumab in Recurrent/Metastatic HNSCCRecruitingNCT06052839Phase 2
- A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 ExpressionRecruitingNCT06051695Phase 1/2
- Clinical, Genetic and Environmental Determinants of Prostate Cancer Progression.RecruitingNCT06046131Not applicable
- JY231 Injection in the Treatment of Relapsed or Refractory B-cell LymphomaRecruitingNCT06045585Early Phase 1
- Adjuvant Therapy for High-risk Hepatocellular Carcinoma Post Liver TransplantationNot yet recruitingNCT06041490Phase 2
- GTP Regimen in the Treatment of Refractory/Recurrent HLHNot yet recruitingNCT06038422Phase 3
- A Dose Escalation and Dose Expansion Study of Intratumoral ONM-501 Alone and in Combination With Cemiplimab in Patients With Advanced Solid Tumors and Lymphomas.RecruitingNCT06022029Phase 1
- Safety and Efficacy of VB10.16 and Pembrolizumab in Patients With Head-Neck Squamous Cell CarcinomaRecruitingNCT06016920Phase 1/2
- The Efficacy of Nigella Sativa Oil Mouth Rinse in the Management of Recurrent Minor Aphthous UlcerNot yet recruitingNCT06013202Not applicable
- Trial of Nab-Sirolimus in Combination With Letrozole in Patients With Advanced or Recurrent Endometrioid Endometrial CancerRecruitingNCT05997017Phase 2
- Study of Mogamulizumab With DA-EPOCH or CHOEP in Patients With Aggressive T-cell LymphomaRecruitingNCT05996185Phase 2
- Risk Factors, Prognosis, and Potential Chemoprevention Drugs in Patients With Recurrent Hepatocellular Carcinoma After Curative Surgeries: a Nationwide Retrospective Cohort Study and a Multi-center Prospective Cohort AnalysisRecruitingNCT05990959
- Decitabine and Selinexor in Combination to Reverse Drug Resistance With Standard Chemotherapy in Ovarian CancerRecruitingNCT05983276Phase 2
- Study of TBI-2001(Autologous CD19 Specific Chimeric Antigen Receptor (CAR) Gene-transduced T Lymphocytes) for Relapsed or Refractory CD19+ B-cell Lymphoma, CLL/SLLRecruitingNCT05963217Phase 1
- A Study of Factors Influencing Recurrence After Thermal Ablation of Papillary Thyroid CarcinomaRecruitingNCT05962892
- IMA402 T Cell-Engaging Receptor Molecule (TCER®) in Recurrent and/or Refractory Solid TumorsRecruitingNCT05958121Phase 1/2
- CD70 Targeted CAR-T Cells in CD70 Positive Relapsed/Refractory LymphomaRecruitingNCT05948033Phase 1/2
- Prospective Clinical Study of ZPR Regimen in Relapsed/Refractory Diffuse Large B-cell LymphomaRecruitingNCT05940051Phase 2
- A Study of GFH009 Monotherapy in Patients with Relapsed or Refractory Peripheral T-cell Lymphoma (PTCL)RecruitingNCT05934513Phase 1/2
- The Study of the Combination of Thiotepa and Pomalidomide for the Treatment of Relapsed/Refractory Primary Central Nervous System Lymphoma Patients.RecruitingNCT05931328Phase 2
- A Study Evaluating the Safety, Pharmacokinetics, and Activity of the Combination of Cevostamab and Elranatamab in Participants With Relapsed or Refractory Multiple Myeloma (R/R MM)RecruitingNCT05927571Phase 1
- Orelabrutinib Combined With Rituximab and Chemotherapy for Relapsed/Refractory B-Cell Lymphoma Patients With Central Nervous System InvolvementRecruitingNCT05926427Phase 2
- Observational Trial Evaluating Elevated Factor VIII Related Labs as a Biomarker for Incomplete Relapse RecoveryNot yet recruitingNCT05926167